Phaarmasia Ltd

AI
Phaarmasia Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents
AI

Phaarmasia Ltd

₹
- close price
phaarmasia.in BSE: 523620
About

Incorporated in 1981, Phaarmasia Ltd is engaged in manufacturing and marketing of Cosmetics, Oral Contraceptive Pills (OCP) and Combipack with Iron Tablets

Key Points

OCP-Led Pharmaceutical Business:[1]
Phaarmasia primarily manufactures and
sells oral contraceptive pills, with other
products including cosmetics and combi
packs with iron tablets. In FY25, government
and other OCP sales contributed ₹18.57 Cr,
or about 76% of the company's ₹24.37 crore operating revenue.[2]

-Unit I Divestment Changed the Manufacturing Base:[3]
Shareholders approved the sale of Unit
I's land and building for at least ₹25 crore
to fund business requirements, including
working capital, debt reduction and facility upgrades.[4]
The unit was transferred during December
2025 quarter; FY26 recorded ₹25.83 crore
of sale proceeds and a ₹18.99 crore exceptional gain, while property, plant and equipment fell from ₹12.28 crore to ₹1.03 crore.[5][6][7]

Website BSE
  • Market Cap ₹ Cr.
  • Current Price ₹
  • High / Low ₹ /
  • Stock P/E
  • Book Value ₹
  • Dividend Yield %
  • ROCE %
  • ROE %
  • Face Value ₹
Edit ratios

Pros

Cons

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Edit Columns
Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Operating Profit
OPM %
Interest
Depreciation
Profit before tax
Tax %
EPS in Rs
Raw PDF

Profit & Loss

Figures in Rs. Crores

Operating Profit
OPM %
Interest
Depreciation
Profit before tax
Tax %
EPS in Rs
Dividend Payout %
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: %
TTM: %
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: %
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: %
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: %

Balance Sheet

Figures in Rs. Crores

Equity Capital
Reserves
Total Liabilities
CWIP
Investments
Total Assets

Cash Flows

Figures in Rs. Crores

Net Cash Flow
Free Cash Flow
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit

Ratios
Debtor Days
Inventory Days
Days Payable
Cash Conversion Cycle
Working Capital Days
ROCE %

Insights

In beta
Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
OCP Sales as % of Total Revenue
% ・Standalone data

Log in to view insights

Please log in to see hidden values.

Login
Number of Permanent Employees
employees ・Standalone data
Actual Tablet Production
Million units ・Standalone data
Installed Capacity - Tablets
Million units per annum ・Standalone data
Tablet Capacity Utilization
% ・Standalone data

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
73.51% 73.51% 73.51% 73.51% 73.51% 73.51% 73.51% 73.51% 73.51% 73.51% 73.51% 73.51%
0.05% 0.05% 0.05% 0.05% 0.05% 0.05% 0.05% 0.05% 0.05% 0.05% 0.05% 0.05%
26.43% 26.43% 26.43% 26.43% 26.43% 26.43% 26.42% 26.44% 26.44% 26.43% 26.43% 26.43%
No. of Shareholders 20,68820,68220,64220,59620,61220,62020,51220,49720,40420,30120,28620,282

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports